More than one-third of patients undergoing catheter-directed thrombolysis of deep vein thrombosis receive an inferior vena cava (IVC) filter, yet placement of the device is not associated with a ...
Inferior vena cava filters have emerged as a popular tool to reduce risk for pulmonary embolism. Nevertheless, their use can be a polarizing issue among physicians. “Many physicians would say that ...
The FDA cleared BiO2 Medical’s catheter for the protection of critically ill patients from pulmonary embolism. It is the first venous catheter to be approved for prophylactic use in addition to ...
The treatment of choice for proximal venous thrombosis is anticoagulation. In situations where anticoagulation is absolutely contraindicated or when anticoagulation has failed in the face of an acute ...
New York, Dec. 16, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "EU5 Clot Management Devices Market Outlook to 2025 - CDT Catheters, Embolectomy Balloon Catheters, ...
Hemodialysis is a life-sustaining renal replacement therapy used to manage ESRD by removing waste products and excess fluids from the blood. While this procedure significantly improves the quality of ...
Catheter-associated thrombosis is the most common noninfectious complication of implantable venous access devices and can cause superior vena cava syndrome. The diagnosis can be confirmed with Doppler ...
The gold standard of vascular access for chronic hemodialysis patients is the arteriovenous fistula (AVF). If an AVF cannot be created, the hemodialysis catheter can be inserted into the internal ...
SAN ANTONIO, March 11, 2013 /PRNewswire/ -- BiO2 Medical, Inc., a Texas based medical device manufacturer with corporate offices in San Antonio, Texas, and R&D and manufacturing operations in Golden, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results